Purpose: Clinical staging of gastric cancer appears to be important more and more for tailored therapy. This study aimed to verify the accuracy of clinical T staging in a low-volume institute. Materials and Methods: We retrospectively reviewed prospectively collected data of gastric cancer patients who underwent resection. A total of 268 patients of gastric cancer were enrolled from March 2004 to June 2012. These demographics, tumor characteristics, and clinical stages were analyzed for identification of diagnostic value of clinical T staging.
Introduction
Gastric cancer is one of the most common malignant diseases in worldwide, and 5-year survival rate has been reported to be approximately 27~52%. The specimens obtained by surgical resection were histopathologically evaluated, and this histopathological data were used as reference standards for the T staging. Histologic T staging was based on the 7th edition of American Joint Committee on Cancer staging system of gastric cancer. (9) (10) (11) Authors' criteria of clinical T staging were adopted in gastrointestinal inter-department conference after review of published articles. (12, 13) Most of these cases were discussed in preoperative inter-department weekly conference, and the clinical stage by gastroscopy and S-CT was determined in this conference. Endoscopic diagnosis of T stage was reviewed by three endoscopists for whether the diagnosis supports the criteria, and final diagnosis was made by consensus of three endoscopists. All S-CT images were reviewed by two experienced radiologists and clinical stage was made by their consensus. The endoscopists and radiologists were blinded to each other's finding and pathologic data.
Endoscopic staging
The endoscopes used in the study were mainly the GIF-H260
and GIF-Q260 (Olympus, Tokyo, Japan). A macroscopic classification of EGC lesions were classified as follows: type I (protruded), type IIa (superficial elevated), type IIb (flat), type IIc (superficial depressed), type III (excavated) and analyzed as two groups according to existence of ulceration. (12, 13) Macroscopic classification of AGC lesions were followed as Borrmann's classification.
Endoscopic criteria for T staging were as follows ( 
Statistical analysis
Quantitative results were expressed as the mean±standard deviation. Analysis was performed using chi-square test or Fisher's Of 282 lesions, 16 lesions were not able to be reviewed for the endoscopic T staging because of bad picture quality or no remained endoscopic picture, and these were excluded from endoscopic staging (Table 2) . Of 266 lesions, 160 lesions were preoperatively diagnosed as EGC by gastroscopy. Predictive value and accuracy for EGC with gastroscopy was 90.0% and 90.2%, respectively. S-CT was taken in 168 lesions, and the cases examined by CT without stomach protocol were excluded from CT staging. Of these, 104
lesions were predicted as EGC. Predictive value and accuracy for EGC with S-CT were 89.4% and 87.5%, respectively. EGC lesions that were preoperatively diagnosed by both gastroscopy and S-CT were 104. Predictive value and accuracy with this combination method were 89.4% and 87.3%, respectively.
The depth of invasion was estimated as cT1a, cT1b and cT2 or more lesions, and these were matched with pathologic result (Table   3) . By S-CT, 90.2% of 61 pT1a lesions were cT1a and 8.2% were In pT1 cancers, overstaged lesions as AGC by S-CT were 10 cases (9.7%) and those characteristics are shown in S-CT = stomach protocol computed tomography; AGC = advanced gastric cancer. *One unidentified lesion (cT1a or cT1b) by S-CT was pT1a cancer, not shown in Table. † One unidentified lesion (cT1a or cT1b) by gastroscopy was pT1b cancer, not shown in Table. as less invasive treatment is favored, endoscopic or laparoscopic treatment is widely accepted and concerned as a minimally invasive treatment modality. There have been not a few reports about diagnostic accuracy of gastroscopy and S-CT from high volume tertiary hospitals.
Ahn et al. (7) demonstrated that predictive value and accuracy for EGC with gastroscopy were 87.4% and 83.4%, respectively. Predictive value and accuracy for EGC with S-CT were reported as 78~92.2% and 81.3~86.4%, respectively. (7, 15) In this study, predictive value and accuracy for EGC with gastroscopy was 90.0% and 90.2%, and with S-CT were 89.4% and 87.5%, respectively. In our institute, diagnosing the gastric cancer lesion as EGC versus AGC, predictive value and accuracy were similar to those of other reports.
In detail, the reported predictive value and accuracy for T1a with gastroscopy were 82.0~83.2% and 73.7~82.7%, respectively, and for T1b with gastroscopy were 58.7~71.9% and 73.7~82.0%, respectively.(9) With S-CT, their predictive value and accuracy for T1a were 83.3~88.6% and 91.3~92.9%, respectively, and for T1b with S-CT were 87.1~92.0% and 90.6~92.1%, respectively.(9) However, when it was evaluated for detailed stages, diagnostic power for T1a In conclusions, diagnostic accuracy of EGC was 90%, which is comparable to those of high volume center. In patients with EGC, limited gastrectomy or minimal invasive surgery can be safely introduced at a low volume center also. However, the surgeon of lowvolume institute should consider the accuracy of clinical staging before extending the indication of limited treatment.
